Osaic Holdings
PFE icon

Osaic Holdings’s Pfizer PFE Stock Holding History

Osaic Holdings’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.1M Buy
2,661,858
+287,169
+12% +$7.51M 0.08% 271
2026
Q1 		$66.7M Buy
2,374,689
+327,529
+16% +$8.72M 0.1% 215
2025
Q4 		$51M Sell
2,047,160
-417,400
-17% -$10.5M 0.07% 264
2025
Q3 		$61.5M Buy
2,464,560
+432,720
+21% +$10.7M 0.09% 230
2025
Q2 		$49.5M Buy
2,031,840
+367,973
+22% +$8.58M 0.09% 219
2025
Q1 		$42.2M Sell
1,663,867
-31,546
-2% -$825K 0.09% 216
2024
Q4 		$44.7M Buy
1,695,413
+42,246
+3% +$1.15M 0.1% 199
2024
Q3 		$47.9M Sell
1,653,167
-147,767
-8% -$4.31M 0.11% 191
2024
Q2 		$50.4M Sell
1,800,934
-143,217
-7% -$3.94M 0.12% 165
2024
Q1 		$54M Sell
1,944,151
-673,313
-26% -$18.7M 0.12% 172
2023
Q4 		$75.4M Sell
2,617,464
-1,069,212
-29% -$32.3M 0.13% 151
2023
Q3 		$122M Buy
3,686,676
+1,120,858
+44% +$39.6M 0.18% 115
2023
Q2 		$94.1M Buy
2,565,818
+59,137
+2% +$2.3M 0.17% 120
2023
Q1 		$102M Buy
2,506,681
+58,688
+2% +$2.53M 0.19% 105
2022
Q4 		$125M Buy
2,447,993
+190,590
+8% +$9.14M 0.25% 87
2022
Q3 		$98.8M Buy
2,257,403
+20,834
+0.9% +$1.01M 0.23% 91
2022
Q2 		$117M Buy
2,236,569
+78,423
+4% +$4M 0.26% 77
2022
Q1 		$107M Sell
2,158,146
-81,683
-4% -$4.24M 0.21% 88
2021
Q4 		$132M Buy
2,239,829
+10,519
+0.5% +$521K 0.25% 80
2021
Q3 		$95.9M Buy
2,229,310
+138,644
+7% +$6.14M 0.2% 96
2021
Q2 		$81.9M Buy
2,090,666
+88,276
+4% +$3.43M 0.18% 116
2021
Q1 		$72.6M Buy
2,002,390
+72,036
+4% +$2.56M 0.17% 117
2020
Q4 		$71.1M Sell
1,930,354
-116,891
-6% -$4.29M 0.19% 109
2020
Q3 		$71M Buy
2,047,245
+176,800
+9% +$6.2M 0.21% 102
2020
Q2 		$58M Sell
1,870,445
-1,649,057
-47% -$56M 0.19% 112
2020
Q1 		$52.3M Buy
+3,519,502
New +$120M 0.21% 104

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Osaic Holdings's PFE Position: Q2 2026 in Review

Osaic Holdings increased its Pfizer (PFE) stake by 12% in Q2 2026, buying an estimated $7.51M and bringing the position to 2,661,858 shares worth $64.1M. The position accounts for 0.08% of the portfolio, ranked #271.

Osaic Holdings first reported a position in PFE in Q1 2020 and has held it in 26 quarters since. The position peaked at $132M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Osaic Holdings held 2,661,858 shares of Pfizer worth $64.1M as of Q2 2026.
  • Osaic Holdings bought 287,169 Pfizer shares in Q2 2026, an estimated $7.51M.
  • Pfizer made up 0.08% of Osaic Holdings's portfolio in Q2 2026, its #271 holding.
  • Osaic Holdings first reported a position in Pfizer in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Pfizer position peaked at $132M in Q4 2021.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.